Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (431-440 of 567) with videos related to

Pageof 57
Sort By:
JAMA|April 14, 1989
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspectiveR M Califf, F E Harrell, K L Lee, et al.
Journal of the American College of Cardiology|May 1, 1991
Restenosis after coronary angioplasty: an overviewR M Califf, D F Fortin, D J Frid, et al.
Circulation|September 1, 1988
Surgical survival benefits for coronary disease patients with left ventricular dysfunctionE P Bounous, D B Mark, B G Pollock, et al.
The American Journal of Cardiology|October 26, 2001
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogramY Birnbaum, S Goodman, A Barr, et al.
Circulation|November 1, 1990
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variablesK L Lee, D B Pryor, K S Pieper, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology|May 1, 1985
Prognostic value of a coronary artery jeopardy scoreR M Califf, H R Phillips, M C Hindman, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Pageof 57

Showing results (431-440 of 567) with videos related to

Sort By:
Pageof 57
JAMA|April 14, 1989
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspectiveR M Califf, F E Harrell, K L Lee, et al.
Journal of the American College of Cardiology|May 1, 1991
Restenosis after coronary angioplasty: an overviewR M Califf, D F Fortin, D J Frid, et al.
Circulation|September 1, 1988
Surgical survival benefits for coronary disease patients with left ventricular dysfunctionE P Bounous, D B Mark, B G Pollock, et al.
The American Journal of Cardiology|October 26, 2001
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogramY Birnbaum, S Goodman, A Barr, et al.
Circulation|November 1, 1990
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variablesK L Lee, D B Pryor, K S Pieper, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Journal of the American College of Cardiology|May 1, 1985
Prognostic value of a coronary artery jeopardy scoreR M Califf, H R Phillips, M C Hindman, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Pageof 57